Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy
NCT ID: NCT01953380
Last Updated: 2017-04-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
400 participants
INTERVENTIONAL
2013-10-31
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Immune Reactions in Contact Dermatitis Affected Skin
NCT01546298
A Prospective Study to Investigate Contact Sensitization Using Classic and Machine Learning Techniques
NCT05991674
Allergic Disease Onset Prevention Study
NCT05003804
Internet and Social Media Use in Dermatology Patients
NCT03913598
Efficacy and Safety of a Purified Standardised Bee Venom Preparation
NCT00263952
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
extended information
Extended information on specific allergy
extended information
Information according to clin. routine
Information according to clinical routine
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
extended information
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age above 18 years
* Participants have given informed consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Region Skane
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andreas Sonesson
MD PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andreas Sonesson, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Region Skåne, Hudkliniken SUS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hudmottagningen SUS
Lund, Skåne County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mossing K, Dizdarevic A, Svensson A, Sonesson A. Impact on quality of life of an intervention providing additional information to patients with allergic contact dermatitis; a randomized clinical trial. J Eur Acad Dermatol Venereol. 2022 Nov;36(11):2166-2171. doi: 10.1111/jdv.18412. Epub 2022 Jul 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ISICA-13
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.